SCHEMBL20161862

SCHEMBL20161862

C=CC(=O)N1CCCNC[C@H]1C(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.33
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL221429 0.81 LMNA (0.35)
SCHEMBL4369740 0.80 SRC (0.35) SRCMAPK1
SCHEMBL27242753 0.76 PARP1 (0.41)
SCHEMBL15322517 0.75 SRC (0.34) SRCMAPK1
SCHEMBL21169298 0.70 CHRNB2 (0.33)
SCHEMBL190726 0.70 PARP1 (0.33)
SCHEMBL18997579 0.70 CHRNB2 (0.33)
SCHEMBL23595333 0.69 DPP4 (0.37) SRC
SCHEMBL4206630 0.69 F2 (0.33)
SCHEMBL16117959 0.69 DPP4 (0.37) SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089261-A2 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed